| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study [Epub ahead of print]
|
Mollel, E.; Lekule, I.; Lynen, L.; Decroo, T.
|
International Health |
2019
|
Article-P
|
|
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study [Epub ahead of print]
|
Tadesse, M.; Abebe, G.; Bekele, A.; Bezabih, M.; Yilma, D.; Apers, L.; de Jong, B. C.; Rigouts, L.
|
Clinical Microbiology and Infection |
2019
|
Article-P
|
|
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study [Epub ahead of print]
|
Tadesse, M.; Abebe, G.; Bekele, A.; Bezabih, M.; Yilma, D.; Apers, L.; de Jong, B. C.; Rigouts, L.
|
Clinical Microbiology and Infection |
2018
|
Article-P
|
|
Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold [letter]
|
Decroo, T.; Henriquez-Trujillo, A.R.; De Weggheleire, A.; Lynen, L.
|
BMC Infectious Diseases |
2017
|
Comment-E
|